Recombinant Anti-Human HTR7 Antibody scFv Fragment (CAT#: MOB-2993z-S(P))

1. Q 1: What research applications can the Anti-Human HTR7 scFv Fragment be utilized for?

   A: The Recombinant Anti-Human HTR7 scFv Fragment is primarily used in immunological assays such as ELISA and Western blotting to identify and quantify the presence of the human serotonin receptor 7 (HTR7). This receptor plays a role in various neuropsychiatric and gastrointestinal studies, helping researchers explore serotonin's effects on mood, cognition, and intestinal functions.

2. Q 2: Which diseases can be studied using this antibody?

   A: The antibody targets the human 5-Hydroxytryptamine (Serotonin) Receptor 7, involved in neurological and psychiatric conditions such as depression, anxiety, and schizophrenia. By binding specifically to HTR7, researchers can study receptor expression changes in these disorders, enhancing the understanding of serotonin's impact on mental health and opening avenues for developing novel therapeutics.

3. Q 3: What are the primary targets and interactions of the HTR7 receptor?

   A: HTR7 is a serotonin receptor coupled to adenylate cyclase, influencing the levels of cyclic AMP in cells. Its primary targets include various neural pathways where it regulates circadian rhythm, thermoregulation, mood, and learning. By interacting with G proteins, HTR7 moderates neurotransmitter release, making it a critical focus for understanding serotonin-mediated signaling.

View the frequently asked questions answered by Creative Biolabs Support.